BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/3/2020 1:28:57 AM | Browse: 710 | Download: 1686
 |
Received |
|
2019-07-12 03:01 |
|
Peer-Review Started |
|
2019-07-16 07:45 |
|
To Make the First Decision |
|
2019-08-08 00:47 |
|
Return for Revision |
|
2019-08-14 04:36 |
|
Revised |
|
2019-10-02 21:26 |
|
Second Decision |
|
2019-12-06 02:53 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-12-09 04:02 |
|
Articles in Press |
|
2019-12-09 04:02 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-12-23 02:37 |
|
Publish the Manuscript Online |
|
2020-01-03 01:28 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020 Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Francisco Leonardo Galastri, Felipe Nasser, Breno Boueri Affonso, Leonardo Guedes Moreira Valle, Bruno Calazans Odísio, Joaquim Mauricio Motta-Leal Filho, Paolo Rogério Salvalaggio, Rodrigo Gobbo Garcia, Márcio Dias de Almeida, Ronaldo Hueb Baroni and Nelson Wolosker |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Francisco Leonardo Galastri, MD, PhD, Staff Physician, Department of Interventional Radiology, Hospital Israelita Albert Einstein, Avenida Albert Einstein, 627, São Paulo 05652-000, Brazil. francisco.galastri2@einstein.br |
| Key Words |
Hepatocellular carcinoma; Liver transplantation; Response evaluation criteria in solid tumors; Neoadjuvant therapy; Liver neoplasms; |
| Core Tip |
This is the first prospective study performed with standardized drug-eluting bead transarterial chemoembolization technique that aim to identify predictors of radiological response, assessing patients clinical and laboratory characteristics, diagnostic imaging and intraprocedure data of the hepatocellular carcinoma treated in the neoadjuvant context for liver transplantation. Two hundred patients with 380 hepatocellular carcinomas were examined and we could conclude that the presence of a pseudocapsule and the addition of the amount of chemoembolic agent increases the chance of an objective response and increases the percentage of tumor necrosis in hepatocellular carcinoma following drug-eluting bead chemoembolization in the neoadjuvant treatment, prior to liver transplantation. |
| Publish Date |
2020-01-03 01:28 |
| Citation |
Galastri FL, Nasser F, Affonso BB, Valle LGM, Odísio BC, Motta-Leal Filho JM, Salvalaggio PR, Garcia RG, de Almeida MD, Baroni RH, Wolosker N. Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma. World J Hepatol 2020; 12(1): 21-33 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i1/21.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i1.21 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
